Colorectal cancer is not only one of the most common, but also one of the most preventable cancers globally. Screening for colorectal cancer has been associated with reduced diseasespecific mortality through detection of cancer at earlier stages, as well as through detection and removal of its precursor lesions.While most professional guidelines recommend routine screening of asymptomatic adults older than 50 years for colorectal cancer, there is disagreement on the age to stop screening. For example, the US Preventive Services Task Force (USPSTF) and the American College of Gastroenterology recommend screening until age 75 years, followed by individualized decision-making for people older than 75 years. 1,2 In contrast, the Canadian Task Force on Preventive Health does not recommend screening adults 75 years and older for colorectal cancer. 3 Likewise, the Asia Pacific Colorectal Cancer Working Group recommends 75 years as a reasonable age limit to stop screening. 4 Nonetheless, these recommendations were largely made based on evidence from modeling studies 5 and indirect evidence, such as reduced life expectancy in older individuals, and disparate inclusion of older adults in colorectal cancer screening trials. 3 Amid the scant empirical data on when best to stop offering colorectal cancer screening, in this issue of JAMA Oncology, Ma et al 6 examine the association between lower endoscopy (colonoscopy and sigmoidoscopy) and the risk of colorectal cancer, as well as its mortality in older adults (older than 75 years). By performing a robust analysis of data from 2 large prospective cohort studies, the Nurses' Health Study and the Health Professionals Follow-up Study, the authors have demonstrated that irrespective of prior endoscopic screening history, screening via colonoscopy or sigmoidoscopy after age 75 years was associated with significantly lower incidence of colorectal cancer (multivariable hazard ratio [HR], 0.61; 95% CI, 0.51-0.74) and colorectal cancer-related mortality (HR, 0.60; 95% CI, 0.46-0.78). It was also reported that no survival benefit was observed with screening endoscopy after age 75 years in participants who had cardiovascular disease (HR, 1.18; 95% CI, 0.59-2.35) or significant comorbidities (HR, 1.17; 95% CI, 0.57-2.43). Therefore, this study appears to address a widely debated topic by providing empirical evidence that points toward a reduction in risk of colorectal cancer, as well as a survival gain associated with screening colonoscopy or sigmoidoscopy in individuals older than 75 years who have no substantial comorbidities, regardless of whether they have undergone prior endoscopic screening.